Clinical Development Architect
About us
Opial supports players in the pharmaceutical, biotechnology and medical device industries in the design, operational implementation and coordination of their clinical developments.
Expert, flexible and pragmatic, Opial structures your activities to make the most of your innovations.
Opial streamlines your clinical development strategies in line with operational and regulatory constraints, and supports your teams on a day-to-day basis to facilitate and clarify decision-making.
As the cornerstone of your clinical development, Opial will be the architect of your clinical studies, drawing on proven experience and, if necessary, mobilising experts and opinion leaders to increase your probability of success.
Opial is particularly well suited to innovative structures, providing them with significant clinical experience or additional resources that can be rapidly mobilised.
David Salako
Founder
With a biomedical and managerial background, David Salako has over 25 years’ experience in clinical development at international level. He has been involved in the clinical development of several major biotech companies, including Erytech Pharma, Inventiva, Genfit and Maat Pharma. Throughout his career, he has developed expertise in clinical development, particularly in the areas of oncology, hematology and rare diseases. Today, he puts his unique experience of clinical development at the service of all innovations in medical products.
Opial is a member of a network of consultants specialising in clinical development, providing complementary expertise.
You must be logged in to post a comment.